Tweet
<img alt="" height="1" width="1" />
Glaxo's Avandia increases heart risks: US reviewer
Reuters
WASHINGTON (Reuters) - An analysis by US government scientists found GlaxoSmithKline Plc's controversial diabetes drug Avandia increased heart risks and deaths compared to a rival pill, according to an email from a Food and Drug Administration reviewer ...
FDA Scientist Attacks Avandia SafetyWall Street Journal
Draft Study Links Avandia to Thousands of Heart Attacks, StrokesNewsinferno.com
Avandia Side Effects May Have Hurt or Killed 100000 People: Draft StudyAboutLawsuits.com
Financial Times -FiercePharma -Government Accountability Project (blog)
all 15 news articles »
More...